Difference between revisions of "Silva IA, et al. Cancer Res. (2011) cited as Ref 731 in DOI: 10.1038/s41392-020-0110-5 (Q9994)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 71, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival (English) | ||
| Property / title: Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:07, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Silva IA, et al. Cancer Res. (2011) cited as Ref 731 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Silva IA
0 references
2011
0 references
Cancer Res.
0 references
71
0 references
Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival (English)
0 references
